Table 1.
Gene | Primer Sequence (5′->3′) |
---|---|
BAX | F: GGCACCTCTTCCCTCCTTTCT |
R: CGATGCGCTTGAGACACTCG | |
BCL2 | F: TTCTTTGAGTTCGGTGGGGT |
R: GGGCCGTACAGTTCCACAA | |
p21 | F: GAAGAGAAACCCCCAGCTCC |
R: TGACTGCATCAAACCCCACA | |
p53 | F: TACTCCCCTGCCCTCAACAA |
R: AGGAATCAGGGCCTTGAGGA | |
IL-1β | F: TATGTGTGTGATGCAGCTGTG |
R: ACTCAAATTCCACGTTGCCC | |
IL-6 | F: CGTCACTCCAGTTGCCTTCT |
R: GCCAGTACCTCCTTGCTGTT | |
TNF α | F: TCCTACCCGTCCAAGGTCAA |
R: CTCATACCAGGGCTTGGCTT | |
IL-10 | F: CTAGGGAACGAAGCATCCAGG |
R: TCAGGAGAGAGGTACCACAGG | |
IL-18 | F: CGCACCCCAGACCGTATTTA |
R: CGCTAGACCTCTAGTGAGGC | |
CFLAR | F: CCACTTAGGAAACAGCTGCC |
R: AGGCCTTGAGGCTACTGACT | |
CRSL1 | F: TGGGCCAGTCAAAAATCAGC |
R: TTCGCGGTGTTGGAAGAGTT | |
MALT1 | F: ATGATGTGCGACGCCTATGT |
R: AGCTGCCAGTTTCTTCAGGT | |
CARD9 | F: CAGCAACTCCTGTGGCTCAT |
R: GCACTCGTCCTCGTTCTCAT | |
NLRP3 | F: CGACACTCTGACATGGACCG |
R: GGCTGAGAAGAGGCTCTGAC | |
MAP2K1 | F: ACTGGGAAAGCTTGGGATGC |
R: CAGTTCCCCAACCTTCTGCT | |
MAP2K2 | F: CGCAGGACTTCCAGGAGTTT |
R: CATCTTCAGATCCGCTCGCT | |
MAPK8 | F: GTTGGGTGCATCATGGGAGA |
R: CAGGACATGGTGTTCCAAGC | |
MAPK14 | F: GAACGTTGTTTCCTGGCACA |
R: TCTTGCAGACTCTGAGGAGATTT | |
NFKB | F: CTTCCTTCGAGCCAGTGACG |
R: CCAGGAGACTTGCTGTCGTG | |
IKK | F: GGCGGTTGACATTAGCACAG |
R: CTGAAGCCGAACCACAGTCT | |
NFKBIA | F: CACTTCACCTTCGTGAGGCT |
R: TGTCACAGGACACAACTGGG | |
TLR1 | F: GTGAGTGGTGCCATTATGAG |
R: CGCGTTTAGATTCAGGTC | |
TLR2 | F: TCGCCGGGACTCTCTTTCTC |
R: GGCCTTGAGGTTCACACACT | |
TLR3 | F: GACTGATGCTCCGAAGGGTG |
R: GGTTTGCGTGTTTCCAGAGC | |
PGC1A | F: GGCCTTCTAAACGTGGGACA |
R: CCGGAGGTCTGCCATTTTCT | |
FIS1 | F: GGTGCGAAGCAAGTACAACG |
R: GTTGCCCACAGCCAGATAGA | |
MFN1 | F: AAGTGGCATTTTTCGGCAGG |
R: TCCATATGAAGGGCATGGGC | |
MFN2 | F: AGGTGAAGTCAGAATTGGTGGA |
R: CTTCACAGGGGTGGCATCAT | |
Parkin | F: TCCCAGTGGAGGTCGATTCT |
R: CCCTCCAGGTGTGTTCGTTT | |
PINK1 | F: GCACAATGAGCCAGGAGCTA |
R: GGGGTATTCACGCGAAGGTA | |
GAPDH | F: GATGCCCCAATGTTTGTGA |
R: AAGCAGGGATGATGTTCTGG |
BAX BCL-2-associated X protein, BCL-2 B-cell lymphoma 2, p21 cyclin-dependent kinase inhibitor 1A, p53 tumor suppressor p53, IL-1β Interleukin1β, IL-6 Interleukin 6, TNFα tumor necrosis factor, IL-10 interleukin 10, IL-18 interleukin 18, CFLAR CASP8 and FADD-like apoptosis regulator, CRSL1 cardiolipin synthase 1, MALT1 mucosa-associated lymphoid tissue lymphoma translocation protein 1, CARD9 Caspase recruitment domain-containing protein 9, NLRP3 NLR family pyrin domain containing 3, MAP2K1 dual specificity mitogen-activated protein kinase kinase 1, MAP2K2 mitogen-activated protein kinase kinase 2, MAPK8 mitogen-activated protein kinase 8, MAPK14: mitogen-activated protein kinase 14, NFKB nuclear factor kappa B, IKK IkappaB kinase, NFKBIA nuclear factor kappa-B inhibitor, TLR1 toll-like receptor 1, TLR2 toll-like receptor 2, TLR3 toll-like receptor 3, PGC1A peroxisome proliferator-activated receptor-gamma coactivator, FIS1 mitochondrial fission 1 protein, MFN1 mitofusin-1, MFN2 mitofusin-2, MFF mitochondrial fission factor, PARKIN E3 ubiquitin ligase parkin, PINK1 PTEN induced kinase 1, GAPDH glyceraldehyde 3-phosphate dehydrogenase